正念认知疗法治疗躯体症状障碍患者的临床疗效观察
Clinical Efficacy Observation of Mindfulness-Based Cognitive Therapy for the Treatment of Patients with Somatic Symptom Disorders
DOI: 10.12677/ap.2024.147477, PDF,   
作者: 王方方：天津中医药大学管理学院，天津；毛稚霞：天津中医药大学第二附属医院心身科，天津
关键词: 躯体症状障碍；正念认知疗法；临床研究；Somatic Symptom Disorder； Mindfulness-Based Cognitive Therapy； Clinical Research
摘要: 目的：探讨正念认知疗法治疗躯体症状障碍患者的有效性。方法：通过将60例躯体症状障碍患者随机分为心理干预联合西药组和单纯西药组，每组各30人，分别予以正念认知疗法进行心理干预联合服用草酸艾司西酞普兰和单纯使用草酸艾司西酞普兰治疗8周，评估治疗前后的广泛性焦虑量表(GAD-7)、患者健康问卷抑郁量表(PHQ-9)和躯体症状量表(PHQ-15)的减分率。结果：正念认知疗法联合草酸艾司西酞普兰组比单纯使用草酸艾司西酞普兰组在GAD-7、PHQ-9、PHQ-15方面均有显著改善(P < 0.05)。结论：正念认知疗法为躯体症状障碍的治疗提供了新的思路。
Abstract: Objective: To investigate the effectiveness of mindfulness-based cognitive therapy in treating patients with somatic symptom disorder. Methods: Sixty patients with somatic symptom disorder were randomly divided into two groups, each with 30 patients, who received mindfulness-based cognitive therapy combined with psychological intervention and escitalopram (Lexapro) and received escitalopram alone for 8 weeks. The reduction rates of the Generalized Anxiety Disorder-7 Scale (GAD-7), Patient Health Questionnaire-9 Scale (PHQ-9), and Patient Health Questionnaire-15 Scale (PHQ-15) before and after treatment were evaluated. Results: The group that received mindfulness-based cognitive therapy combined with escitalopram showed significantly better improvement in GAD-7, PHQ-9, and PHQ-15 than the group that received escitalopram alone (P < 0.05). Conclusion: Mindfulness-based cognitive therapy provides a new perspective for the treatment of somatic symptom disorder.
文章引用：王方方, 毛稚霞 (2024). 正念认知疗法治疗躯体症状障碍患者的临床疗效观察. 心理学进展, 14(7), 257-268. https://doi.org/10.12677/ap.2024.147477

参考文献

[1] 陈子晨, 汪新建(2013). 从DSM-Ⅳ躯体形式障碍到DSM-5躯体症状障碍. 心理科学进展, (11), 1967-1975.
[2] 井绪贞, 吴金凤, 孟娟(2021). 小剂量抗精神病药联合心理疗法治疗躯体化障碍的疗效观察. 心理月刊, 16(17), 69-70, 102.[CrossRef] 
[3] 毛稚霞(2022). 躯体症状障碍的非药物治疗进展. 天津中医药大学学报, 41(3), 402-408.
[4] 李媛媛, 王策, 丁晓超, 狄亚琴, 于雪竹, 刘杰(2023). 正念认知疗法联合度洛西汀治疗躯体形式障碍患者焦虑症状的随机对照试验. 中国心理卫生杂志, 37(7), 558-563.
[5] 沈静, 丁卫, 李丹, 李丹洋, 蒋晔(2023). 心理治疗对躯体化障碍患者心理障碍症状的应用效果及患者预后的影响观察. 心理月刊, (24), 131-133.[CrossRef] 
[6] 王海媚(2021). 小剂量抗精神病药联合心理疗法治疗躯体化障碍临床分析. 系统医学, 6(12), 80-82.[CrossRef] 
[7] 谢芳, 龙敏琴, 鄢骏, 丁文娟(2023). 正念认知疗法对躯体形式障碍患者心理状态、述情障碍及治疗依从性的影响. 中国当代医药, 30(22), 60-63.
[8] 尹志香, 刘飞艳, 王俊凤(2024). 认知行为干预对首发躯体形式障碍患者的影响. 心理月刊, (3), 185-187.[CrossRef] 
[9] 虞安娜, 李燕, 包祖晓, 何聪聪, 陈宝君(2023). 正念训练治疗青少年躯体症状障碍的临床疗效观察. 临床精神医学杂志, 33(5), 405.
[10] 袁春媛(2021). 小剂量抗精神病药联合心理疗法治疗躯体化障碍的临床效果. 世界复合医学, 7(10), 166-170.
[11] 张红胜(2020). 心理治疗对躯体化障碍患者心理障碍症状的有效性及对患者预后的影响. 河北医药, 42(20), 3130-3133.
[12] 郑恩雨, 王可, 冯雪竹, 朱维莉, 陆林, 时杰, 李素霞(2022). 躯体症状障碍相关研究进展. 中国药物依赖性杂志, 31(6), 407-410, 416.[CrossRef] 
[13] Jang, Y. E., Jang, Y., Choi, H. Y., & Park, H. Y. (2021). The Relationships between Cognitive Control and Psychological Symptoms in Patients with Somatic Symptom Disorder: A Pilot Longitudinal Study. Cognitive Neuropsychiatry, 26, 242-256.[CrossRef] [PubMed]
[14] Kim, S. M., Hong, J. S., Min, K. J., & Han, D. H. (2019). Brain Functional Connectivity in Patients with Somatic Symptom Disorder. Psychosomatic Medicine, 81, 313-318.[CrossRef] [PubMed]
[15] Prior, K. N., & Bond, M. J. (2013). Somatic Symptom Disorders and Illness Behaviour: Current Perspectives. International Review of Psychiatry, 25, 5-18.[CrossRef] [PubMed]
[16] Tian, P., Ma, Y., Hu, J., Zhou, C., Liu, X., Chen, Q. et al. (2021). Clinical and Psychobehavioral Features of Outpatients with Somatic Symptom Disorder in Otorhinolaryngology Clinics. Journal of Psychosomatic Research, 148, Article ID: 110550.[CrossRef] [PubMed]